WASHINGTON (dpa-AFX) - Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):
Earnings: -$83.76 million in Q4 vs. -$137.87 million in the same period last year. EPS: -$0.65 in Q4 vs. -$1.10 in the same period last year. Excluding items, Alnylam Pharmaceuticals Inc. reported adjusted earnings of $8.05 million or $0.06 per share for the period.
Analysts projected -$0.14 per share Revenue: $593.17 million in Q4 vs. $439.72 million in the same period last year.
Copyright(c) 2025 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2025 AFX News
